Team Maureen


HPV-Associated Oropharyngeal Cancers Increasing in the U.S.

HPVAssociated Oropharyngeal Cancers Increasing in the US
A new national report on cancer incidence trends 1 presents data of relevance for dentists and the public. First, the report provides encouraging long-term data on declining death rates for several common cancer types, but it also presents significant data on the increasing incidence rates of human papillomavirus (HPV)-associated cancers of the oropharynx, including the base of the tongue and tonsils.

updated: 3 years ago

Accelerating the HPV Vaccine Uptake: Urgency for Action to Prevent Cancer

Human papillomaviruses (HPV) cause most cases of cervical cancer and large proportions of vaginal, vulvar, anal, penile, and oropharyngeal cancers. HPV also causes genital warts and recurrent respiratory papillomatosis. HPV vaccines could dramatically reduce the incidence of HPV-associated cancers and other conditions among both females and males, but uptake of the vaccines has fallen short of target levels. The President's Cancer Panel finds underuse of HPV vaccines a serious but correctable threat to progress against cancer. In this report, the Panel presents four goals to increase HPV vaccine uptake: three of these focus on the United States and the fourth addresses ways the United States can help to increase global uptake of the vaccines. Several high-priority research questions related to HPV and HPV vaccines also are identified...

updated: 3 years ago

Human papillomavirus: a strong case for vaccinating boys

In the UK, human papilloma virus vaccination is restricted on the NHS to girls and only recently been recommended for men who have sex with men. The restriction is based largely on cost-effectiveness. In this article, Gillian Prue sets out the compelling case for vaccinating all boys. On page 10, Peter Baker describes HPV Action’s campaign for gender-neutral HPV vaccination.

updated: 3 years ago

What are the key statistics about oral cavity and oropharyngeal cancers?

What are the key statistics about oral cavity and oropharyngeal cancers

The American Cancer Society’s most recent estimates for oral cavity and oropharyngeal cancers in the United States are for 2016:

  • About 48,330 people will get oral cavity or oropharyngeal cancer.
  • An estimated 9,570 people will die of these cancers.

These cancers are more than twice as common in men as in women...

updated: 3 years ago

HPV risk for oral cancer | Dana-Farber Cancer Institute

HPV risk for oral cancer nbspDanaFarber Cancer Institute

updated: 3 years ago

Cervical Cancer

Could Making Cancer Screening Simpler Increase Women's Risk?

A proposal to simplify cervical cancer screening could end up missing some cancers, researchers and patient advocates say. And that could be especially true for minority women.

updated: 2 years ago

Sweetening connection between cancer and sugar

Scientists have found that some types of cancers have more of a sweet tooth than others.

updated: 1 year ago

What you should know about Cervical Cancer

Unlike many gynecologic cancers, there is a vaccination and screening test for cervical cancer, an important distinction in preventing and identifying the disease, according to Ursula Matulonis, MD, medical director of Gynecologic Oncology in Dana-Farber’s Susan F. Smith Center for Women’s Cancers, and Colleen Feltmate, MD, director of minimally invasive surgery in Gynecologic Oncology at Brigham and Women’s Hospital.

updated: 2 years ago

Wider Racial Gap Found in Cervical Cancer Deaths

The death rate from cervical cancer in the United States is considerably higher than previously estimated and the disparity in death rates between black women and white women is significantly wider, according to a study published Monday in the journal Cancer.

updated: 3 years ago

Nonsurgical Management of Cervical Cancer: Locally Advanced, Recurrent, and Metastatic Disease, Survivorship, and Beyond

Despite the declining incidence of cervical cancer as a result of the introduction of screening programs, globally it remains a leading cause of cancer-related death in women. Outcomes for patients who are diagnosed with anything but early-stage disease remain poor.

updated: 4 years ago